Trends in cardiovascular engineering: Organizing the human heart

Trends in Cardiovascular Medicine

Volumn 23, Issue 8, 2013, Pages 282-286

  Tulloch, Nathaniel L ^a   Murry, Charles E ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Washington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR NKX2.5;

CELL PROLIFERATION; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; EXPERIMENTAL MODEL; FETUS HEART; GROWTH REGULATION; HEART; HEART CONTRACTION; HEART DEVELOPMENT; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERTROPHY; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

CELL PROLIFERATION; FORECASTING; HEART; HUMANS; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; TISSUE ENGINEERING;

EID: 84884819111     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2013.04.001     Document Type: Review

References (38)

1. Badie N., Bursac N. Novel micropatterned cardiac cell cultures with realistic ventricular microstructure. Biophysical Journal 2009, 96:3873-3885.
2. Benton J.A., Fairbanks B.D., Anseth K.S. Characterization of valvular interstitial cell function in three dimensional matrix metalloproteinase degradable PEG hydrogels. Biomaterials 2009, 30:6593-6603.
3. Benton J.A., Kern H.B., Anseth K.S. Substrate properties influence calcification in valvular interstitial cell culture. Journal of Heart Valve Disease 2008, 17:689-699.
4. Birla R.K., Huang Y.C., Dennis R.G. Development of a novel bioreactor for the mechanical loading of tissue-engineered heart muscle. Tissue Engineering 2007, 13:2239-2248.
5. Carvajal-Vergara X., Sevilla A., D'Souza S.L., Ang Y.S., Schaniel C., Lee D.F., et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 2010, 465:808-812.
6. Caspi O., Lesman A., Basevitch Y., Gepstein A., Arbel G., Habib I.H., et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circulation Research 2007, 100:263-272.
7. Chiu L.L., Montgomery M., Liang Y., Liu H., Radisic M. Perfusable branching microvessel bed for vascularization of engineered tissues. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:E3414-E3423.
8. Dar A., Shachar M., Leor J., Cohen S. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnology and Bioengineering 2002, 80:305-312.
9. Eschenhagen T., Didie M., Munzel F., Schubert P., Schneiderbanger K., Zimmermann W.H. 3D engineered heart tissue for replacement therapy. Basic Research in Cardiology 2002, 97(Suppl. 1):I146-I152.
10. Fink C., Ergun S., Kralisch D., Remmers U., Weil J., Eschenhagen T. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB Journal 2000, 14:669-679.
11. Grünig E., Tasman J.A., Kücherer H., Franz W., Kübler W., Katus H.A. Frequency and phenotypes of familial dilated cardiomyopathy. Journal of the American College of Cardiology 1998, 31:186-194.
12. Kreutziger K.L., Muskheli V., Johnson P., Braun K., Wight T.N., Murry C.E. Developing vasculature and stroma in engineered human myocardium. Tissue Engineering Part A 2011, 17:1219-1228.
13. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology 2007, 25:1015-1024.
14. Liau B., Christoforou N., Leong K.W., Bursac N. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials 2011, 32:9180-9187.
15. Lu S.J., Feng Q., Caballero S., Chen Y., Moore M.A., Grant M.B., et al. Generation of functional hemangioblasts from human embryonic stem cells. Nature Methods 2007, 4:501-509.
16. Madden L.R., Mortisen D.J., Sussman E.M., Dupras S.K., Fugate J.A., Cuy J.L., et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:15211-15216.
17. Manolio T.A., Baughman K.L., Rodeheffer R., Pearson T.A., Bristow J.D., Michels V.V., et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). American Journal of Cardiology 1992, 69:1458-1466.
18. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study, coronary artery risk development in (young) adults. Circulation 1995, 92:785-789.
19. Marsano A., Maidhof R., Wan L.Q., Wang Y., Gao J., Tandon N., et al. Scaffold stiffness affects the contractile function of three-dimensional engineered cardiac constructs. Biotechnology Progress 2010, 26:1382-1390.
20. Moretti A., Bellin M., Welling A., Jung C.B., Lam J.T., Bott-Flügel L., et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. New England Journal of Medicine 2010, 363:1397-1409.
21. Mummery C.L., Ward D., Passier R. Differentiation of human embryonic stem cells to cardiomyocytes by coculture with endoderm in serum-free medium. Current Protocols in Stem Cell Biology 2007, [Chapter 1:Unit 1F.2].
22. Murry C.E., Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
23. Naito H., Melnychenko I., Didie M., Schneiderbanger K., Schubert P., Rosenkranz S., et al. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 2006, 114:I72-I78.
24. Nourse M.B., Halpin D.E., Scatena M., Mortisen D.J., Tulloch N.L., Hauch K.D., et al. VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 30:80-89.
25. Paul M., Zumhagen S., Stallmeyer B., Koopmann M., Spieker T., Schulze-Bahr E. Genes causing inherited forms of cardiomyopathies: a current compendium. Herz 2009, 34:98-109.
26. Radisic M., Park H., Martens T.P., Salazar-Lazaro J.E., Geng W., Wang Y., et al. Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. Journal of Biomedical Materials Research Part A 2008, 86:713-724.
27. Sadoul N., de Chillou C., Aliot E., McKenna W.J. Evaluation of the risk of sudden death in hypertrophic cardiomyopathy. Archives Des Maladies Du Coeur Et Des Vaisseaux 1999, 92 Spec No 1:65-73.
28. Schaaf S., Shibamiya A., Mewe M., Eder A., Stöhr A., Hirt M.N., et al. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 2011, 6:e26397.
29. Shapira-Schweitzer K., Seliktar D. Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial. Acta Biomaterialia 2007, 3:33-41.
30. Stevens K.R., Kreutziger K.L., Dupras S.K., Korte F.S., Regnier M., Muskheli V., et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:16568-16573.
31. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
32. Tee R., Morrison W.A., Dusting G.J., Liu G.S., Choi Y.S., Hsiao S.T., et al. Transplantation of engineered cardiac muscle flaps in syngeneic rats. Tissue Engineering Part A 2012, 18:1992-1999.
33. Tulloch N.L., Muskheli V., Razumova M.V., Korte F.S., Regnier M., Hauch K.D., et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circulation Research 2011, 109:47-59.
34. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., Kattman S.J., Kennedy M., et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
35. Zhu W.Z., Van Biber B., Laflamme M.A. Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells. Methods in Molecular Biology 2011, 767:419-431.
36. Zimmermann W.H., Didie M., Wasmeier G.H., Nixdorff U., Hess A., Melnychenko I., et al. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 2002, 106:I151-I157.
37. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., Nixdorff U., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nature Medicine 2006, 12:452-458.
38. Zimmermann W.H., Schneiderbanger K., Schubert P., Didie M., Munzel F., Heubach J.F., et al. Tissue engineering of a differentiated cardiac muscle construct. Circulation Research 2002, 90:223-230.